Sinotherapeutics Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 111.41 million compared to CNY 42.42 million a year ago. Net income was CNY 22.9 million compared to CNY 7.72 million a year ago.

Basic earnings per share from continuing operations was CNY 0.05 compared to CNY 0.02 a year ago. Diluted earnings per share from continuing operations was CNY 0.05 compared to CNY 0.02 a year ago.